KORU Medical Systems, Inc. (KRMD) research

KORU Medical Systems, Inc.
ShareXLinkedInReddit
Sector
Healthcare
Industry
Medical Instruments & Supplies
Last price
$3.27
As of

KORU Medical Systems, Inc. (KRMD): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-14.

As of . Source: SEC EDGAR filings for KRMD. Method and limitations.

SHARE THIS CARD

Share the KRMD intelligence card

A branded snapshot of KRMD: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion KRMD intelligence card preview
Post to X
LIVE TERMINAL

See KRMD live in the terminal

Track KRMD's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live KRMD terminal, free

Active signals for KRMD

FREE, NO ACCOUNT

Every signal on KRMD, as it fires

You are seeing 5 of 15 signals recorded on KRMD since 2026-06-09.

The five above all landed on 2026-09-06. The other 10 were recorded on 2 other days. 12 of the 15 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in KRMD (2026Q2)

Manager / securityMarket value% portfolioQoQ
RENAISSANCE TECHNOLOGIES LLCCUSIP 759910102 · 2026Q2$693K0.00%,
CITADEL ADVISORS LLCCUSIP 759910102 · 2026Q2$120K0.00%,
MILLENNIUM MANAGEMENT LLCCUSIP 759910102 · 2026Q2$69K0.00%,
TWO SIGMA INVESTMENTS, LPCUSIP 759910102 · 2026Q2$61K0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, KRMD

KRMD against its peers

KRMD's operating margin of -7.2% ranks in the 62nd percentile of 19 Medical Instruments & Supplies sub-industry peers, fiscal periods ending between 2025-06-30 and 2026-06-30.

MetricKRMDPeer medianPercentilen
Revenue FY41.1M USD32.4M USD6319
Gross margin62.3%57.4%6216
Operating margin-7.2%-55.3%6319
Net margin-6.4%-36.4%6319
Return on equity-15.5%-47.2%6819

Peers (22): NYXH, ZJYL, STXS, PDEX, UTMD, NNNN, MBOT, OSUR, EMBC, SMTI, POCI, NEPH, MLSS, HBIO, AVR, FEMY, RVP, KMTS, BNGO, RGNT, BLFS, UEEC. Left out: DXR (no annual filing), ZTEK (no annual filing), AZTA (no annual filing). Fiscal periods ending between 2025-06-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (KRMD: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more KRMD signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to KRMDand get the insider, 13F, options, and confluence read in one view.

Open the live KRMD terminal, free